Randomized clinical trials towards a single‐visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG‐101 in chronic hepatitis C patients and long‐acting injectable GSK2878175 in healthy participants.
Autor: | Deng, Yanli1 (AUTHOR), Campbell, Fiona2 (AUTHOR), Han, Kelong1 (AUTHOR), Theodore, Dickens3 (AUTHOR), Deeg, Mark4 (AUTHOR), Huang, Michael4 (AUTHOR), Hamatake, Robert3 (AUTHOR), Lahiri, Soumi1 (AUTHOR), Chen, Shuguang1 (AUTHOR), Horvath, Gabor5 (AUTHOR), Manolakopoulos, Spilios6 (AUTHOR), Dalekos, George N.7 (AUTHOR), Papatheodoridis, George6 (AUTHOR), Goulis, Ioannis8 (AUTHOR), Banyai, Tivadar9 (AUTHOR), Jilma, Bernd10 (AUTHOR), Leivers, Martin3 (AUTHOR) martin.r.leivers@gsk.com |
---|---|
Zdroj: | Journal of Viral Hepatitis. Jul2020, Vol. 27 Issue 7, p699-708. 10p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |